Thomas Secher

5PUBLICATIONS
11CO-AUTHORS
Gene and molecular therapyMolecular targetsAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 22, 2022
Alternative Routes of Administration for Therapeutic Antibodies-State of the Art.

Aubin Pitiot, Nathalie Heuzé-Vourc'h, Thomas Sécher

|Aug 02, 2022
A Protective Role of NOD2 on Oxazolone-induced Intestinal Inflammation Through IL-1β-mediated Signalling Pathway.

Thomas Secher, Aurélie Couturier, Ludovic Huot

|Mar 26, 2022
Aggregates Associated with Instability of Antibodies during Aerosolization Induce Adverse Immunological Effects.

Thomas Sécher, Elsa Bodier-Montagutelli, Christelle Parent

|May 07, 2021
Chronic Pseudomonas aeruginosa Lung Infection Is IL-1R Independent, but Relies on MyD88 Signaling.

Claire Mackowiak, Tiffany Marchiol, Hana Cipcic Paljetak

Pageof 1